Patients with HR+/HER2− metastatic breast cancer without previous systemic therapy were randomly assigned to receive either ...

A new global competition offering over $500,000 in prizes aims to spur drug discovery breakthroughs for the cancer target ...

Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...

As health care practitioners evaluate AI strategies, panelists in a TBBJ roundtable discussion urge attention to its impact ...

Researchers from the University of Lübeck and the University Medical Center Schleswig-Holstein (UKSH), Campus Lübeck, ...

A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...

Machine learning doesn’t replace humans. But AI does assist them in doing their job better by helping predict the success – ...

With a decade-long collaboration history, the companies have previously demonstrated the value of their combined analysis ...

Stacey Stevens, who has ample experience using artificial intelligence to aid with cancer treatment, replaces co-founder Tushar Pandey.

A new artificial intelligence tool combines data from medical images with text to predict cancer prognoses and treatment responses.

In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...